EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2009;35:977-987. doi:10.1016/j.ejcts.2009.02.014
Copyright © 2009, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Corrigendum (v36,p608)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Venugopal, V.
Right arrow Articles by Hausenloy, D. J.
PubMed
Right arrow Articles by Venugopal, V.
Right arrow Articles by Hausenloy, D. J.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Cardiac - physiology
Right arrow Myocardial protection


Review

‘Conditioning’ the heart during surgery

Vinod Venugopal, Andrew Ludman, Derek M. Yellon, Derek J. Hausenloy*

The Hatter Cardiovascular Institute, University College London Hospital, 67 Chenies Mews, London, WC1E 6HX, United Kingdom

Received 18 September 2008; received in revised form 15 January 2009; accepted 10 February 2009.

* Corresponding author. Tel.: +44 207 380 9888; fax: +44 207 380 9505. (Email: d.hausenloy{at}ucl.ac.uk).

Coronary heart disease (CHD) is the leading cause of death worldwide. Coronary artery bypass graft (CABG) surgery remains the procedure of choice for coronary artery revascularisation in a large number of patients with severe CHD. However, the profile of patients undergoing CABG surgery is changing with increasingly higher-risk patients being operated upon, resulting in significant morbidity and mortality in this patient group. Myocardial injury sustained during cardiac surgery, most of which can be attributed to acute myocardial ischaemia–reperfusion injury, is associated with worse short-term and long-term clinical outcomes. Clearly, new treatment strategies are required to protect the heart during cardiac surgery in terms of reducing myocardial injury and preserving left ventricular systolic function, such that clinical outcomes can be improved. ‘Conditioning’ the heart to harness its endogenous cardioprotective capabilities using either brief ischaemia or pharmacological agents, provides a potentially novel approach to myocardial protection during cardiac surgery, and is the subject of this review article.

Key Words: Cardioprotection • Cardioplegia • Intermittent cross-clamp fibrillation • Ischaemic preconditioning • Pharmacological preconditioning • Remote ischaemic preconditioning • Ischaemic postconditioning




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Heusch and R. Schulz
Neglect of the coronary circulation: some critical remarks on problems in the translation of cardioprotection
Cardiovasc Res, October 1, 2009; 84(1): 11 - 14.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.